Yves Collette

13PUBLICATIONS
180CO-AUTHORS
Haematological tumoursGlycoconjugatesGene and molecular therapyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 29, 2025
Dual targeting of CDK6 and LSD1 is synergistic and overcomes differentiation blockade in AML.

Lise Brault, Edwige Voisset, Mathieu Desaunay

|Apr 19, 2024
INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia Treatment.

Manuela Bratti, Elisa Stubbs, Sergii Kolodych

|Mar 28, 2024
Venetoclax Resistance in Acute Myeloid Leukemia.

Sylvain Garciaz, Marie-Anne Hospital, Yves Collette

|Oct 11, 2023
Downregulation of stromal syntenin sustains AML development.

Raphael Leblanc, Rania Ghossoub, Armelle Goubard

|Jun 16, 2023
CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia.

Thomas Farge, Jean Nakhle, Damien Lagarde

Pageof 3